RayBiotech, Inc. and Innopsys Announce Co-Marketing Partnership
RayBiotech, Inc. today announced that it has entered into a co-marketing partnership with Innopsys of Carbonne, France to promote the sales of RayBiotech’s G-Series and Quantibody series of antibody arrays and array testing services with Innopsys’ Innoscan laser microarray scanning... - April 13, 2012
RayBiotech, Inc. Engages Industry Expert for Business Development & Growth Advisory Services
RayBiotech, Inc., today announced that it has engaged recognized industry expert, David A. Dodd of RiversEdge BioVentures LLC to work with the Company in the areas of Business Development and Strategic Growth Opportunities. - November 10, 2011
Raybiotech Launches Risk-Free Trial Program for ELISA Kits
RayBiotech, Inc., has just launched a Risk-Free Trial on its ELISA kits, stipulating that if a researcher is unsatisfied with the performance of any RayBio® ELISA, EIA, or phosphorylation ELISA, they can receive a full product refund or credit. - July 22, 2011
RayBiotech Renews Biomarker Discovery Grants for 2011
RayBiotech, Inc., announced today it will renew its Biomarker Discovery Pilot Grant program for 2011. RayBiotech will accept applications for pilot grants beginning in early 2011. Winning applicants will be eligible for restricted grants of $5,000 to $20,000 worth of RayBiotech products and/or services. This is the second year RayBiotech has sponsored these grants to demonstrate the application of antibody-based products to biomarker discovery. - December 04, 2010
RayBiotech Launches Th17 Antibody Arrays for Immune Research
RayBiotech, Inc., the Protein Array Pioneer Company, today announced the release of several antibody array products that can detect up to 34 proteins related to the recently discovered Th17 lineage of immune cells. Th17 cells have been linked to the immune response to fungal and certain bacterial infections, as well being associated with several autoimmune diseases, including lupus, rheumatoid arthritis, Crohn's disease and multiple sclerosis. - November 03, 2010
RayBiotech Awarded NIH/STTR Grant for Endometriosis Research
RayBiotech, Inc., a leading developer and supplier of multiplex protein and antibody arrays, was recently awarded an STTR research grant to identify protein markers that could potentially be used in a diagnostic test for endometriosis. - October 22, 2010
RayBiotech and Gentel Partner to Offer Comprehensive Selection of Arrays on APiX Chromogenic Detection Platform
RayBiotech, Inc., a pioneer and leader in protein and antibody array technologies, and Gentel Biosciences, a leader in proteomics profiling tools, jointly announced today their partnership to develop and market RayBiotech's vast collection of easy-to-use antibody array products for use with Gentel's APiX™ chromogenic detection platform, a cost-effective alternative to laser fluoresecence scanners. - October 05, 2010
RayBiotech Announces Biomarker Grant Awardees
RayBiotech, Inc., the Protein Array Pioneer Company, has announced the winners of its Biomarker Discovery Pilot Grant program. In total, 18 award recipients were chosen for grants of up to $20,000 each, redeemable for RayBiotech products and services. "By offering these grants," states Dr. - May 06, 2010
Biomarker Discovery Grant Deadline Extended
RayBiotech, Inc., today announced that they are extending the deadline for submitting applications for its Biomarker Discovery Pilot Grant program. RayBiotech will now accept applications for the pilot grants through February 22nd, 2010. “The last-minute surge in interest in the grant program has been overwhelming,” said Brett Burkholder, Director of Marketing & Business Development for RayBiotech, Inc. - February 02, 2010
Role of YAP in Cancer Revealed Using EGFR Phosphorylation Array
A study, published in the December 2009 issue of Nature Cell Biology, identified amphiregulin (AREG) as the key effector molecule in YAP-mediated proliferation of breast epithelial cells. Since AREG is a a diffusible, secreted factor, it represents a new potential drug target for cancer. Two antibody arrays from RayBiotech were instrumental in this discovery; one is a unique array detecting phosphorylation of EGFR family receptors at multiple sites. - January 29, 2010
RayBiotech Introduces Multiplex ELISA Detecting 200 Human Proteins
RayBiotech, the Protein Array Pioneer Company, has just introduced the Quantibody® Human Cytokine Array 4000 (or Human Q4000, catalog number QAH-CAA-4000), which can quantitatively detect expression of 200 different proteins in a single experiment. The kit consists of 5 different quantitative... - December 12, 2009
RayBiotech to Award Biomarker Discovery Grants
RayBiotech, Inc., today announced today the establishment of its Biomarker Discovery Pilot Grant program, consisting of restricted grants of $10,000 to $20,000 worth of RayBiotech products and services to conduct their proposed biomarker research, which would potentially be sufficient to generate preliminary data for additional grant funding. - September 26, 2009
RayBiotech Now Offers Nearly 500 ELISA Kits
RayBiotech, the Protein Array Pioneer Company, has just increased its product line of different ELISA kits to 495, including ones detecting cytokines, chemokines, growth factors, angiogenic factors and adipokines in human, mouse, and rat samples. - June 03, 2009